157 related articles for article (PubMed ID: 23183427)
1. Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia.
Noguera NI; Song MS; Divona M; Catalano G; Calvo KL; García F; Ottone T; Florenzano F; Faraoni I; Battistini L; Colombo E; Amadori S; Pandolfi PP; Lo-Coco F
Leukemia; 2013 Apr; 27(5):1037-43. PubMed ID: 23183427
[TBL] [Abstract][Full Text] [Related]
2. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.
Song MS; Salmena L; Carracedo A; Egia A; Lo-Coco F; Teruya-Feldstein J; Pandolfi PP
Nature; 2008 Oct; 455(7214):813-7. PubMed ID: 18716620
[TBL] [Abstract][Full Text] [Related]
3. HAUSP compartmentalization in chronic myeloid leukemia.
Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Saglio G
Eur J Haematol; 2015 Apr; 94(4):318-21. PubMed ID: 25082234
[TBL] [Abstract][Full Text] [Related]
4. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
5. BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP.
Morotti A; Panuzzo C; Crivellaro S; Pergolizzi B; Familiari U; Berger AH; Saglio G; Pandolfi PP
Leukemia; 2014 Jun; 28(6):1326-33. PubMed ID: 24317448
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic expression of nucleophosmin 1 as a marker for diagnosing residual disease of acute myeloid leukemia.
Dai Q; Ren Y
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):205-11. PubMed ID: 23591014
[TBL] [Abstract][Full Text] [Related]
8. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
Falini B
Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
[TBL] [Abstract][Full Text] [Related]
10. The equilibrium of tumor suppression: DUBs as active regulators of PTEN.
Christine A; Park MK; Song SJ; Song MS
Exp Mol Med; 2022 Nov; 54(11):1814-1821. PubMed ID: 36385557
[TBL] [Abstract][Full Text] [Related]
11. Selective Toxicity of Investigational Ixazomib for Human Leukemia Cells Expressing Mutant Cytoplasmic NPM1: Role of Reactive Oxygen Species.
Garcia JS; Huang M; Medeiros BC; Mitchell BS
Clin Cancer Res; 2016 Apr; 22(8):1978-88. PubMed ID: 26634271
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical demonstration of mutant nucleophosmin in acute myeloid leukemia: biological and clinical features related to NPMc expression].
Bedekovics J; Rejto L; Telek B; Udvardy M; Ujfalusi A; Oláh E; Hevessy Z; Kappelmayer J; Kajtár B; Méhes G
Orv Hetil; 2009 May; 150(22):1031-5. PubMed ID: 19465351
[TBL] [Abstract][Full Text] [Related]
14. XPO1 is a new target of homoharringtonine (HHT): Making NPMc
Xue J; Chu P; Gao W; Wang F; Gao Y; Liu S; Kang Z; Yan J; Wang H
Biochem Biophys Res Commun; 2023 Oct; 675():155-161. PubMed ID: 37473530
[TBL] [Abstract][Full Text] [Related]
15. HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator.
Bhattacharya S; Ghosh MK
FEBS J; 2014 Jul; 281(13):3061-78. PubMed ID: 24823443
[TBL] [Abstract][Full Text] [Related]
16. NPM1 mutant maintains ULK1 protein stability via TRAF6-dependent ubiquitination to promote autophagic cell survival in leukemia.
Tang Y; Tao Y; Wang L; Yang L; Jing Y; Jiang X; Lei L; Yang Z; Wang X; Peng M; Xiao Q; Ren J; Zhang L
FASEB J; 2021 Feb; 35(2):e21192. PubMed ID: 33201521
[TBL] [Abstract][Full Text] [Related]
17. A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).
Liso A; Castiglione F; Cappuccio A; Stracci F; Schlenk RF; Amadori S; Thiede C; Schnittger S; Valk PJ; Döhner K; Martelli MF; Schaich M; Krauter J; Ganser A; Martelli MP; Bolli N; Löwenberg B; Haferlach T; Ehninger G; Mandelli F; Döhner H; Michor F; Falini B
Haematologica; 2008 Aug; 93(8):1219-26. PubMed ID: 18603563
[TBL] [Abstract][Full Text] [Related]
18. A Curious Novel Combination of
Venanzi A; Rossi R; Martino G; Annibali O; Avvisati G; Mameli MG; Sportoletti P; Tiacci E; Falini B; Martelli MP
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573408
[No Abstract] [Full Text] [Related]
19. NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia.
Falini B; Mecucci C; Saglio G; Lo Coco F; Diverio D; Brown P; Pane F; Mancini M; Martelli MP; Pileri S; Haferlach T; Haferlach C; Schnittger S
Haematologica; 2008 Mar; 93(3):439-42. PubMed ID: 18268276
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives.
Falini B; Sportoletti P; Martelli MP
Curr Opin Oncol; 2009 Nov; 21(6):573-81. PubMed ID: 19770764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
